UC researchers looking for the Goldilocks of exosuits
Studies continue for best version of device that can help take strain off the back
Oh my aching back.
It’s a common complaint, and one that health officials say causes more disability around the world than any other condition.
A new device, however, the exosuit, shows promise in assisting with back and shoulder injury prevention. Still, not one of the devices manufactured to date is “just right” says Vesna Novak, PhD, an electrical engineering and computer science professor at the University of Cincinnati.
Novak’s research team studies exosuits, a wearable mobile machine that allows for limb movement with increased strength and endurance.
Vesna Novak, PhD, leads a research team that studies the performance of exosuits. Photo provided/Novak.
“Nothing has been perfected so we are trying to figure out what works and what doesn’t so we can zero in,” Novak says of the team’s latest research published in the journal Applied Ergonomics. The demand for exosuits is highest among industries where employees do a lot of heavy, repetitive lifting such as in warehouse work, construction work and the airline industry. Exosuits are a less expensive, less cumbersome version of an exoskeleton, which is primarily used in the medical field.
“Back support exosuits can support workers in physically demanding jobs by reducing muscle load, which could reduce risk of work-related musculoskeletal disorders,” she says.
For this study, funded by the National Science Foundation, Novak says they looked at the commercially available Auxivo LiftSuit 1.1 and found both pros and cons.
Auxivo LiftSuit manufacturer has already made a new version of the suit that they say addresses these issues.
Vesna Novak UC professor of electrical engineering and computer science
“Its main weakness is that it's kind of rigid and uncomfortable, so it's good for short-term but not medium-term wear,” says the study’s lead author Maja Gorsic, a postdoctoral researcher under Novak’s tutelage.
Although study participants found the tasks mildly to moderately easier to perform with the exosuit than without it, “the LiftSuit does not appear to be flexible enough: as it is very stiff around the low back and hips, squatting motions are uncomfortable for wearers,” says Gorsic.
Thus, Novak says, wearers are more likely to lift with their back, leaning their hips back into the exosuit which defeats the purpose. The team compared/contrasted this device with their prior study of the HeroWear Apex suit, which did not appear to have these same issues, but was lacking in other areas.
“Both of the suits had limitations and the Auxivo LiftSuit manufacturer has already made a new version of the suit that they say addresses these issues,” says Novak.
Having academic researchers independently evaluate commercial exoskeletons is common practice, says Novak.
Featured photo at top courtesy of Unsplash/Tromeur.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.